Fundraising FoxvenBio Global Strategic — 2026 Investments
2 investments dated 2026 · listed companies and verified rows first · show all
Entact is a drug discovery company developing treatments for patients.
BiotechDeep TechWatertown, US
Victoria Richon(Executive Officer, Director, Promoter)inRuben Tommasi(Chief Scientific Officer)Michael Gutch(Chief Operating Officer)Alon Lazarus(Director)
BoardAndrew Sinclair(Director)Anna French(Director)in
Board seatRichard Gaster· per SEC Form D · $10M raise · filed Jun 2026
Co-investorsvenBio PartnersAbingworthArkin CapitalQiming Venture Partners
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.